BillionaireNet
Billi
Maurizio Billi
Rank #1033
BRAZILHealthcareGeneric drugs

Maurizio Billi

Net Worth
$3.862B
0% (24h)
Maurizio Billi is a prominent Brazilian businessman and the current President of Eurofarma, a leading pharmaceutical company in Latin America. Born in São Paulo in 1957 to Italian immigrants, Billi has spent his entire career within the Eurofarma Group, starting in 1977. Under his leadership, Eurofarma has expanded significantly, focusing on innovation, quality, and accessibility in healthcare. Billi's estimated net worth is $4.0 billion, making him a significant figure in the global healthcare industry. He is known for his strategic vision and commitment to sustainable growth, ethical practices, and social responsibility. His focus on delivering affordable and high-quality medications has improved public health outcomes across Latin America. Billi also supports various initiatives aimed at improving healthcare access, education, and community development.

The Full Dossier

Early Life

Maurizio Billi was born in São Paulo, Brazil, in 1957. He is the son of Italian immigrants, Galliano Billi and Maria Teresa Caselli, who moved to Brazil after World War II. His parents instilled in him a strong work ethic and entrepreneurial spirit. Galliano, a chemist, founded the Billi Farmacêutica in 1972. Maurizio grew up in an environment that valued education and independent thinking, which shaped his future. At the age of 19, he began working in the family business.

Rise to Success

Maurizio Billi's career is deeply intertwined with Eurofarma. He joined the company in 1977 and rose through the ranks. In 1998, he assumed the presidency of Eurofarma, succeeding his father. Under his leadership, Eurofarma has become a major player in the pharmaceutical industry, with operations in 22 countries and over 10,000 employees. He spearheaded a strategy of expansion into Central and South America, making strategic acquisitions. His leadership emphasized sustainable growth, ethical practices, and social responsibility, constantly investing in research and development.

Key Business Strategies

Billi's business strategies have centered on innovation, quality, and accessibility in healthcare. Key strategies have included aggressive expansion through acquisitions, particularly in Central and South America. He has focused on expanding the company's product line and market presence. He has also overseen the company's investment in biotechnology, artificial intelligence, and personalized medicine. His leadership has also focused on building a strong organizational culture oriented towards sustainability, talent development, and long-term growth.

Philanthropy

Maurizio Billi is known for his philanthropic endeavors and commitment to social causes. He supports various initiatives aimed at improving healthcare access, education, and community development. His commitment to corporate social responsibility is deeply ingrained in Eurofarma’s operations. Billi's philanthropic efforts reflect his belief in giving back to the community and making a positive impact on society.

Career Timeline

1998

President of Eurofarma

Assumed the presidency of Eurofarma.

1977

Began Career at Eurofarma

Started working at Eurofarma, the family-owned pharmaceutical company.

Philanthropic Impact

Healthcare and EducationUndisclosed

Healthcare and Education Initiatives

Supports various initiatives aimed at improving healthcare access, education, and community development.

Wealth Trajectory